INMB vs SPCE · rev $50.0K vs rev $361.0K
INmune Bio Inc (INMB) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
INMB currently screens at market cap $33.5M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the INMB and SPCE stock pages for the full models.
Not investment advice.